from ZeroHedge:
The Texas attorney general is suing pharmaceutical giant Pfizer for misrepresenting the effectiveness of the company’s Covid-19 “vaccine” and for conspiring to censor those who questioned its claims.
The suit, filed Thursday, alleges that Pfizer violated the Texas Deceptive Trade Practices Act by engaging in false, deceptive and misleading acts as it promoted the drug.
“The facts are clear. Pfizer did not tell the truth about their COVID-19 vaccines,” said Attorney General Kenneth Paxton in a statement revealing the suit.
TRUTH LIVES on at https://sgtreport.tv/
“We are pursuing justice for the people of Texas, many of whom were coerced by tyrannical vaccine mandates to take a defective product sold by lies.“
The suit comes about eight months after Paxton announced an investigation of Pfizer, Moderna and Johnson & Johnson for potential misrepresentations about Covid-19 vaccine efficacy and “potential manipulation of vaccine trial data.”
He has accused the company of “unlawfully misrepresenting the effectiveness of the company’s COVID-19 vaccine and attempting to censor public discussion of the product,” according to a press release.
“Pfizer engaged in false, deceptive, and misleading acts and practices by making unsupported claims regarding the company’s COVID-19 vaccine in violation of the Texas Deceptive Trade Practices Act,” the release continues
Much of Paxton’s 54-page-complaint focuses on Pfizer’s December 20, 2020 claim that its vaccine was “95% effective.”
However, according to the complaint, “more Americans died in 2021, with Pfizer’s vaccine available, than in 2020, the first year of the pandemic.” He also cites government reports concluding that in some places, deaths among vaccinated people outpaced those among the unvaccinated, even on a percentage basis.
Pfizer’s claim of 95% efficacy rested on deceptive framing of clinical trial observations, says the complaint:
That number was only ever legitimate in a solitary, highly- technical, and artificial way—it represented a calculation of the so-called “relative risk reduction” for vaccinated individuals in Pfizer’s then-unfinished pivotal clinical trial.
But FDA publications indicate “relative risk reduction” is a misleading statistic that “unduly influence[s]” consumer choice.
Indeed, per FDA: “when information is presented in a relative risk format, the risk reduction seems large and treatments are viewed more favorably than when the same information is presented” using more accurate metrics.
The critical 95% claim came at a point when Pfizer only had an average of two months data on participants, says Paxton.
Specifically, the Texas AG says that of the 17,000 who received a placebo, only 162 contracted the illness, which makes for a poor baseline from which to judge the efficacy of the so-called vaccine.
Had Pfizer used the FDA’s preferred metric — absolute risk reduction — it would have instead informed the public that “the vaccine was merely 0.85% effective,” writes Paxton.
